Skip to content

Longitudinal Study of Dental Implant Therapy in HIV Positive Patients

Longitudinal Study of Dental Implant Therapy in HIV Positive Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01211288
Enrollment
41
Registered
2010-09-29
Start date
2010-05-31
Completion date
2020-05-01
Last updated
2020-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Implant

Keywords

HIV, Implant, Crown

Brief summary

The purpose is to place implants in HIV positive and HIV negative patients then follow patients over 3 years period of time to evaluate how well dental implants perform in HIV positive patients versus HIV negative patients.

Detailed description

This study will review the osseointegration of implant supported restorations in HIV positive and HIV negative patients, then follow patients over a 3 year period of time. The treatment outcome as measured according to Mish criteria for implant success. Patients will be examined at each interval for the presence of pain, infection, mobility, and radiographic bone height of each implant.

Interventions

DEVICEAstra implants

Root form OsseoSpeed TX Astra Tech Implant System

Sponsors

Dentsply Sirona Implants and Consumables
CollaboratorINDUSTRY
University of Alabama at Birmingham
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
19 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy enough to undergo the proposed therapy without compromise to existing health status * At least 19 years old * Able to read and understand written English without the aid of ad hoc interpretation * Able to cognitively understand the proposed study and therapy and possible prognoses * Able to consent for their own inclusion in the study. * Implant supported restorations are limited to the following edentulous areas: Mandibular arch (excluding 2nd and 3rd molar areas), Maxillary anterior and premolar areas

Exclusion criteria

* Smoker * Uncontrolled diabetes * Uncontrolled hypertension * Bisphosphonate user * Bruxer * Extraction site healed less than 6 months * Women pregnant or lactating at the time of enrollment * Previous malignant neoplasm * A known hypersensitivity to Titanium metal * Any medication/condition that in the opinion of the clinical investigators may adversely affect bone healing * Any indication of an inability to make autonomous decisions

Design outcomes

Primary

MeasureTime frameDescription
Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative SubjectsBaseline to 12 months after implant restoration completeDental implant supported restorations functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.

Secondary

MeasureTime frameDescription
Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects12 months after implant restorationRadiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.

Countries

United States

Participant flow

Participants by arm

ArmCount
HIV Negative Group
This group contains participants consented to receive implants and identified as negative for HIV Astra implants: Root form OsseoSpeed TX Astra Tech Implant System
21
HIV Positive Group
This group contains participants consented to receive implants and identified as positive for HIV Astra implants: Root form OsseoSpeed TX Astra Tech Implant System
20
Total41

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up11

Baseline characteristics

CharacteristicHIV Negative GroupHIV Positive GroupTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants0 Participants4 Participants
Age, Categorical
Between 18 and 65 years
17 Participants20 Participants37 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
6 Participants0 Participants6 Participants
Race (NIH/OMB)
Black or African American
1 Participants11 Participants12 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants2 Participants
Race (NIH/OMB)
White
12 Participants9 Participants21 Participants
Region of Enrollment
United States
21 participants20 participants41 participants
Sex: Female, Male
Female
14 Participants5 Participants19 Participants
Sex: Female, Male
Male
7 Participants15 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 14
other
Total, other adverse events
0 / 160 / 14
serious
Total, serious adverse events
0 / 160 / 14

Outcome results

Primary

Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects

Dental implant supported restorations functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.

Time frame: Baseline to 12 months after implant restoration complete

Population: Unable to do follow up on 3 participants - two participants from HIV negative group and one participant from HIV positive group, and one implant failure from HIV positive group

ArmMeasureValue (NUMBER)
HIV Negative GroupNumber of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects28 implants
HIV Positive GroupNumber of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects25 implants
Primary

Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects

Dental Implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.

Time frame: Baseline to 24 months after implant restoration complete

Population: Unable to do follow up on 7 participants, three participants from HIV negative group and four participants from HIV positive group

ArmMeasureValue (NUMBER)
HIV Negative GroupNumber of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects27 implants
HIV Positive GroupNumber of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects20 implants
Primary

Number of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects

Dental implant supported restoration functioning in the mouth with no pain, no mobility, no infection and less than 50% bone loss around the implant site.

Time frame: Baseline to 36 months after implant restoration complete

Population: Unable to do follow up on 11 participants, five participants from HIV negative group and six participants from HIV positive group

ArmMeasureValue (NUMBER)
HIV Negative GroupNumber of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects25 implants
HIV Positive GroupNumber of Implants Functioning in HIV Positive Subjects Compared to HIV Negative Subjects17 implants
Secondary

Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects

Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.

Time frame: 24 months after implant restoration

Population: Unable to do follow up on 7 participants, three from HIV negative group and four from HIV positive group

ArmMeasureValue (MEAN)Dispersion
HIV Negative GroupPeri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects0.39 millmetersStandard Deviation 0.49
HIV Positive GroupPeri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects0.33 millmetersStandard Deviation 0.61
Secondary

Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects

Radiographic examination of implant osseointegration and bone loss by using traditional periapical and /or bitewing radiographs.

Time frame: 36 months after implant restoration

Population: Unable to do follow up on 11 participants, five from HIV negative group and six from HIV positive group

ArmMeasureValue (MEAN)Dispersion
HIV Negative GroupPeri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects0.44 millmetersStandard Deviation 0.52
HIV Positive GroupPeri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects0.48 millmetersStandard Deviation 0.95
Secondary

Peri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects

Radiographic examination of implant osseointegration and bone loss by using traditional periapical and/or bitewing radiographs.

Time frame: 12 months after implant restoration

Population: Unable to do follow up on three participants, two from HIV negative group and one from HIV positive group

ArmMeasureValue (MEAN)Dispersion
HIV Negative GroupPeri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects0.34 millmetersStandard Deviation 0.58
HIV Positive GroupPeri-implant Health and Bone Maintenance as Measured by Radiographic Examination in HIV Positive Subjects Compared to HIV Negative Subjects0.35 millmetersStandard Deviation 0.71

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026